UVV Stock Analysis: Universal | NYSE
Tobacco | NYSE, USA | Market Cap: 1.013m USD | 12M Return: -20.8% | US9134561094 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.3M
EPS Trend: -28.4%
Rev. Trend: 69.7%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Universal Corporation (NYSE: UVV) is a business-to-business agriproducts company headquartered in Richmond, Virginia, operating since 1918. The company runs two main segments: Tobacco Operations, which procures, processes, and packs various types of leaf tobacco (including flue-cured, burley, dark air-cured, and oriental) for consumer product manufacturers, along with specialty services like custom blending, chemical testing, reconstituted leaf manufacturing, and liquid nicotine production; and Ingredients Operations, which produces specialty plant-based ingredients such as fruit and vegetable juices, purees, concentrates, botanical extracts, natural flavors, and nutraceuticals for food, beverage, and consumer-packaged goods manufacturers. This dual structure positions UVV in both the traditional tobacco supply chain and the growing plant-based ingredients market, giving it exposure to consumer staples demand in food and beverage end markets worldwide.
- Leaf tobacco margins pressured by crop costs and FX volatility
- Ingredients segment revenue accelerates on plant-based demand
- Global anti-tobacco regulation pressures leaf tobacco volumes
| Net Income: 19.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.26 > 1.0 |
| NWC/Revenue: 47.96% < 20% (prev 47.68%; Δ 0.28% < -1%) |
| CFO/TA 0.07 > 3% & CFO 217.1m > Net Income 19.1m |
| Net Debt (1.08b) to EBITDA (196.1m): 5.49 < 3 |
| Current Ratio: 2.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.1m) vs 12m ago -0.20% < -2% |
| Gross Margin: 16.82% > 18% (prev 19.27%; Δ -2.45% > 0.5%) |
| Asset Turnover: 91.71% > 50% (prev 92.31%; Δ -0.59% > 0%) |
| Interest Coverage Ratio: 1.90 > 6 (EBIT TTM 143.4m / Interest Expense TTM 75.3m) |
| A: 0.45 (Total Current Assets 2.24b - Total Current Liabilities 870.9m) / Total Assets 3.04b |
| B: 0.37 (Retained Earnings 1.11b / Total Assets 3.04b) |
| C: 0.05 (EBIT TTM 143.4m / Avg Total Assets 3.11b) |
| D: 0.86 (Book Value of Equity 1.39b / Total Liabilities 1.61b) |
| Altman-Z'' = 5.36 = AAA |
| DSRI: 1.04 (Receivables 555.4m/551.9m, Revenue 2.85b/2.94b) |
| GMI: 1.15 (GM 19.27% / 16.82%) |
| AQI: 0.94 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 0.97 (Revenue 2.85b / 2.94b) |
| TATA: -0.07 (NI 19.1m - CFO 217.1m) / TA 3.04b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of October 20, 2026, the stock is trading at USD 39.56 with a total of 380,880 shares traded. Over the past week, the price has changed by -5.61%, over one month by -6.87%, over three months by -24.30% and over the past year by -20.75%.
Current recommended Stop Loss: 38.30 (which is 3.2% or 1.2 ATR below the current price).
Universal has no consensus analysts rating.
| Analysts Target Price | 67 | 69.4% |
P/E Trailing = 53.5132
P/E Forward = 11.976
P/S = 0.3548
P/B = 0.7795
P/EG = 11.978
Revenue TTM = 2.85b USD
EBIT TTM = 143.4m USD
EBITDA TTM = 196.1m USD
Long Term Debt = 616.9m USD (from longTermDebt, last quarter)
Short Term Debt = 577.5m USD (from shortTermDebt, last quarter)
Debt = 1.25b USD (from shortLongTermDebtTotal, last quarter) + Leases 33.3m
Net Debt = 1.08b USD (calculated: Debt 1.25b - CCE 173.6m)
Enterprise Value = 2.09b USD (1.01b + Debt 1.25b - CCE 173.6m)
Interest Coverage Ratio = 1.90 (Ebit TTM 143.4m / Interest Expense TTM 75.3m)
EV/FCF = 12.71x (Enterprise Value 2.09b / FCF TTM 164.4m)
FCF Yield = 7.87% (FCF TTM 164.4m / Enterprise Value 2.09b)
FCF Margin = 5.76% (FCF TTM 164.4m / Revenue TTM 2.85b)
Net Margin = 0.67% (Net Income TTM 19.1m / Revenue TTM 2.85b)
Gross Margin = 16.82% ((Revenue TTM 2.85b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 15.86% (prev 13.77%)
Tobins Q-Ratio = 0.69 (Enterprise Value 2.09b / Total Assets 3.04b)
Interest Expense / Debt = 6.02% (Interest Expense 75.3m / Debt 1.25b)
Taxrate = 45.45% (46.7m / 102.7m)
NOPAT = 78.2m (EBIT 143.4m * (1 - 45.45%))
Current Ratio = 2.57 (Total Current Assets 2.24b / Total Current Liabilities 870.9m)
Debt / Equity = 0.90 (Debt 1.25b / totalStockholderEquity, last quarter 1.39b)
Debt / EBITDA = 5.49 (Net Debt 1.08b / EBITDA 196.1m)
Debt / FCF = 6.55 (Net Debt 1.08b / FCF TTM 164.4m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 19.1m / Total Assets 3.04b)
RoE = 1.33% (Net Income TTM 19.1m / Total Stockholder Equity 1.44b)
RoCE = 6.98% (EBIT 143.4m / Capital Employed (Equity 1.44b + L.T.Debt 616.9m))
RoIC = 3.01% (NOPAT 78.2m / Invested Capital 2.60b)
WACC = 4.13% (E(1.01b)/V(2.26b) * Re(5.17%) + D(1.25b)/V(2.26b) * Rd(6.02%) * (1-Tc(0.45)))
Discount Rate = 5.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.05 | Cagr: -0.05%
[DCF] Terminal Value 77.97% ; FCFF base≈151.6m ; Y1≈173.8m ; Y5≈255.8m
[DCF] Fair Price = 111.3 (EV 3.85b - Net Debt 1.08b = Equity 2.77b / Shares 24.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -28.42 | EPS CAGR: -10.39% | SUE: N/A | # QB: 0
Revenue Correlation: 69.67 | Revenue CAGR: 3.34% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.58 | Chg30d=+0.00% | Revisions=-25% | Analysts=1
EPS next Quarter (2026-12-31): EPS=1.75 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS current Year (2027-03-31): EPS=3.18 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+20.4% | GrowthRev=-6.8%
EPS next Year (2028-03-31): EPS=3.95 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+24.2% | GrowthRev=+4.2%